Introducing the 30/30 Carbon Reduction Initiative

Thépenier Pharma & Cosmetics is proud to announce the launch of its 30/30 Carbon Reduction Initiative, aimed at significantly reducing carbon emissions across all scopes by 2030. This initiative underscores the company's commitment to environmental sustainability and sets a new benchmark in the pharmaceutical industry.

The 30/30 Carbon Reduction Initiative is a bold step towards achieving significant environmental impact reduction. Thépenier Pharma & Cosmetics aims to cut carbon emissions across scopes 1, 2, and 3 by 30% by 2030. This initiative is supported by robust emission tracking systems, ISO 14001 certification, and a commitment to renewable energy sources. With these efforts, the company is not only enhancing its operational sustainability but also contributing to a greener pharmaceutical industry.